Fortress Biotech, Inc. (FBIO) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 16.04M | 16.08M | 17.63M | 16.41M | 13.14M | 15.12M | 14.63M | 14.9M | 13.03M | 19.95M | 34.75M | 17.39M |
| Revenue Growth % | 22.06% | 6.34% | 20.52% | 10.18% | 0.84% | -24.2% | -57.9% | -14.32% | 4.84% | 21.59% | 110.26% | -7.94% |
| Cost of Goods Sold | 7.34M | 5.44M | 5.75M | 4.94M | 4.79M | 5.8M | 5.29M | 6.54M | 6M | 6.01M | 6.43M | 7.77M |
| COGS % of Revenue | 45.79% | 33.83% | 32.64% | 30.09% | 36.46% | 38.39% | 36.13% | 43.91% | 46.06% | 30.16% | 18.5% | 44.67% |
| Gross Profit | 8.69M | 10.64M | 11.88M | 11.47M | 8.35M | 9.31M | 9.34M | 8.36M | 7.03M | 13.93M | 28.32M | 9.62M |
| Gross Margin % | 54.21% | 66.17% | 67.36% | 69.91% | 63.54% | 61.61% | 63.87% | 56.09% | 53.94% | 69.84% | 81.5% | 55.33% |
| Gross Profit Growth % | 4.13% | 14.21% | 27.1% | 37.33% | 18.8% | -33.13% | -67.01% | -13.14% | 17.53% | 77.17% | 204.32% | -14.52% |
| Operating Expenses | 16.43M | 15.43M | 18.69M | 47.95M | 30.67M | 36.66M | 31.44M | 36.14M | 43.59M | 33.55M | 42.08M | 59.72M |
| OpEx % of Revenue | 102.46% | 95.95% | 105.99% | 292.13% | 233.4% | 242.46% | 214.91% | 242.64% | 334.57% | 168.18% | 121.09% | 343.52% |
| Selling, General & Admin | 15.89M | 14.73M | 17.41M | 38.76M | 25.66M | 26.72M | 21.99M | 20.82M | 17.94M | 22.61M | 21.73M | 24.44M |
| SG&A % of Revenue | 99.1% | 91.61% | 98.77% | 236.14% | 195.32% | 176.72% | 150.34% | 139.79% | 137.69% | 113.37% | 62.54% | 140.57% |
| Research & Development | 540K | -367K | 208K | 8.13M | 3.94M | 9.94M | 9.45M | 12.67M | 24.84M | 14.08M | 20.35M | 32.14M |
| R&D % of Revenue | 3.37% | -2.28% | 1.18% | 49.51% | 29.97% | 65.74% | 64.57% | 85.06% | 190.63% | 70.57% | 58.55% | 184.87% |
| Other Operating Expenses | 0 | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 1000K | 814K | -1000K | 0 | 1000K |
| Operating Income | -7.74M | -4.79M | -6.81M | -36.47M | -22.32M | -27.34M | -22.09M | -27.79M | -36.57M | -19.61M | -13.76M | -50.1M |
| Operating Margin % | -48.25% | -29.78% | -38.63% | -222.22% | -169.85% | -180.85% | -151.04% | -186.55% | -280.63% | -98.34% | -39.59% | -288.19% |
| Operating Income Growth % | 65.32% | 82.49% | 69.17% | -31.25% | 38.97% | -39.42% | -60.6% | 44.54% | 37.88% | 64.1% | 72.88% | 1.61% |
| EBITDA | -6.04M | -3.63M | -5.65M | -35.32M | -21.13M | -25.74M | -18.77M | -26.6M | -35.38M | -17.91M | -11.01M | -48.4M |
| EBITDA Margin % | -37.66% | -22.59% | -32.07% | -215.18% | -160.79% | -170.24% | -128.32% | -178.55% | -271.49% | -89.77% | -31.67% | -278.41% |
| EBITDA Growth % | 71.41% | 85.89% | 69.88% | -32.79% | 40.28% | -43.76% | -70.56% | 45.05% | 37.89% | 65.6% | 76.83% | 0.62% |
| D&A (Non-Cash Add-back) | 1.7M | 1.16M | 1.16M | 1.16M | 1.19M | 1.6M | 3.32M | 1.19M | 1.19M | 1.71M | 2.75M | 1.7M |
| EBIT | -7.74M | -4.5M | 11.27M | -9.58M | -22.18M | -23.39M | -24.39M | -27.33M | -37.03M | -27.09M | -8.71M | -54.1M |
| Net Interest Income | -2.8M | -1.07M | -1.68M | -1.45M | -2.02M | -2.07M | -5.62M | -1.39M | -1.77M | -1.35M | -1.99M | -2.91M |
| Interest Income | 570K | 637K | 736K | 622K | 490K | 526K | 589K | 734K | 833K | 707K | 547K | 715K |
| Interest Expense | 3.37M | 1.71M | 2.42M | 2.07M | 2.51M | 2.59M | 6.21M | 2.12M | 2.6M | 2.06M | 2.53M | 3.63M |
| Other Income/Expense | 150.03M | -1.42M | 15.66M | 24.82M | -2.37M | 1.37M | -4.53M | -1.04M | -2.46M | -8.99M | 3.17M | -9.2M |
| Pretax Income | 142.29M | -6.21M | 8.85M | -11.65M | -24.69M | -25.98M | -26.63M | -28.82M | -39.02M | -28.61M | -10.58M | -59.3M |
| Pretax Margin % | 887.23% | -38.64% | 50.21% | -71% | -187.92% | -171.82% | -182% | -193.5% | -299.49% | -143.41% | -30.45% | -341.08% |
| Income Tax | 5.13M | -816K | 26K | 0 | 0 | 336K | 69K | 0 | 0 | 379K | 141K | 0 |
| Effective Tax Rate % | 3.61% | 13.13% | 0.29% | 0% | 0% | -1.29% | -0.26% | 0% | 0% | -1.32% | -1.33% | 0% |
| Net Income | 110.37M | -3.94M | 5.85M | 15.49M | -10.58M | -6.76M | -12.87M | -10.95M | -15.42M | -9.28M | -5.04M | -24.78M |
| Net Margin % | 688.2% | -24.49% | 33.18% | 94.35% | -80.55% | -44.74% | -87.96% | -73.5% | -118.32% | -46.52% | -14.52% | -142.51% |
| Net Income Growth % | 1142.83% | 41.8% | 145.47% | 241.45% | 31.35% | 27.09% | -155.04% | 55.81% | 28.42% | 65.57% | 77.59% | -16.01% |
| Net Income (Continuing) | 137.16M | -5.4M | 8.83M | -11.65M | -24.69M | -26.32M | -26.69M | -28.82M | -39.02M | -28.98M | -10.72M | -59.3M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 40.17M | 12.31M | 9.32M | -6.54M | 10.24M | -24.38M | -33.9M | -32.48M | -26.96M | -20.96M | -29.92M | -34.45M |
| EPS (Diluted) | 2.82 | -0.20 | 0.11 | 0.45 | -0.48 | -0.37 | -0.76 | -0.73 | -1.03 | -1.19 | -0.94 | -3.65 |
| EPS Growth % | 687.5% | 45.95% | 114.47% | 161.64% | 53.4% | 68.91% | 19.15% | 80% | 70.32% | 84.74% | 77.13% | 6.41% |
| EPS (Basic) | 3.44 | -0.22 | 0.13 | 0.50 | -0.48 | -0.37 | -0.76 | -0.73 | -1.03 | -1.19 | -0.94 | -3.65 |
| Diluted Shares Outstanding | 38.41M | 279.02M | 33.1M | 29.82M | 26.45M | 20.24M | 19.7M | 18.32M | 17.15M | 7.8M | 7.5M | 7.38M |
| Basic Shares Outstanding | 31.54M | 27.9M | 27.24M | 26.88M | 26.45M | 20.24M | 19.7M | 18.32M | 17.15M | 7.8M | 7.5M | 7.38M |
| Dividend Payout Ratio | - | - | 2.84% | 1.07% | - | - | - | - | - | - | - | - |